Effects of the anabolic steroid stanozolol on cells derived from human bone
- 1 May 1988
- journal article
- research article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 74 (5) , 455-460
- https://doi.org/10.1042/cs0740455
Abstract
1. In this study, cells derived from explants of human trabecular bone were treated with the anabolic steriod stanozolol in order to determine whether the potential therapeutic effect of this agent might be explained by direct effects on skeletal tissue. 2. Stanozolol at a concentration of 10-10 mol/l to 10-6 mol/l consistently stimulated the incorporation of [3H]thymidine into DNA of human bone cells and increased proliferation. 3. Stanozolol had variable effects on the expression of two other markers of the osteoblast phenotype, namely the bone-specific vitamin-K-dependent protein osteocalcin, and the enzyme alkaline phosphatase. Although atanozolol tended to increase the values, this was not seen in all experiments. 4. We conclude that human bone cells respond to stanozol. The effects of this agent on cell proliferation may be important in understanding the mode of action of this drug in the treatment of osteopenic disorders.This publication has 8 references indexed in Scilit:
- 1,25-Dihydroxyvitamin D3and Human Bone-Derived Cells in Vitro: Effects on Alkaline Phosphatase, Type I Collagen and Proliferation*Endocrinology, 1986
- Stimulation of the proliferation of human bone cells in vitro by human monocyte products with interleukin-1 activity.Journal of Clinical Investigation, 1985
- Stanozolol-Induced Changes in Fibrinolysis and Coagulation in Healthy AdultsThrombosis and Haemostasis, 1984
- Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoidsMetabolic Bone Disease and Related Research, 1984
- Improved method for quantitative determination in serum of alkaline phosphatase of skeletal origin.Clinical Chemistry, 1981
- The fibrinolytic response to stanozolol in normal subjectsThrombosis Research, 1981
- Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal femalesEuropean Journal of Clinical Investigation, 1980
- Distinction between Alpha-Fetoprotein and Intracellular Estrogen Receptors: Evidence against the Presence of Estradiol Receptors in Rat Bone*Endocrinology, 1978